SCHEMBL10869862

SCHEMBL10869862

CN(CCO)c1nc2nc(N3CCNCC3)nc(N3CCSCC3)c2nc1-c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 7/20 0.44
PDE4B Q07343 7/20 0.44
PDE4C Q08493 7/20 0.44
PDE4D Q08499 7/20 0.44
ALDH1A1 P00352 2/20 0.39
HPGD P15428 1/20 0.39
P2RY12 Q9H244 1/20 0.37
SLC9A5 Q14940 1/20 0.36
SLC29A1 Q99808 1/20 0.36
CETP P11597 1/20 0.35
NPSR1 Q6W5P4 3/20 0.35
KDM4E B2RXH2 1/20 0.35
S1PR2 O95136 1/20 0.35
LMNA P02545 1/20 0.35
KMT2A Q03164 1/20 0.35
HIF1A Q16665 1/20 0.35
PIK3CA P42336 1/20 0.34
HTR2C P28335 2/20 0.34
CYP1A2 P05177 2/20 0.33
CYP2C9 P11712 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10869864 0.90 PDE4A (0.42) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL10869629 0.88 ALDH1A1 (0.39) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL10869976 0.82 PDE4A (0.47) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL10869809 0.82 PDE4A (0.49) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL10869789 0.79 PDE4A (0.66) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL10869816 0.79 PIK3CA (0.44) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL10869805 0.78 ALDH1A1 (0.39) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL10870626 0.78 PDE4A (0.41) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL10870557 0.76 PDE4A (0.65) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL10869502 0.75 PDE4A (0.52) PDE4APDE4BPDE4CPDE4DALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0185259-A2 Pteridines, process for their preparation, and their use as intermediates or as medicaments Dr. Karl Thomae GmbH (DE) 1986-06-25 EP disclosed